This Final Report was prepared at MRIGlobal for the work performed under MRIGlobal Task
No. 311788.01.001, “Testing of Airocide Air Purification System against Aerosolized SARSCoV-2.”
The experimental phase of this task was initiated by MRIGlobal on July 27, 2021 and
ended on August 1, 2021.
The test was performed by Rick Tuttle and Kristy Solocinski, Ph.D. She was assisted by Jacob
Wilkinson. The project was managed by William Sosna.
The study was not performed in compliance with the FDA Good Laboratory Practice
Regulations (21 CFR 58) or EPA Good Laboratory Practice Regulations (40 CFR 160). All
operations pertaining to this study, unless specifically defined in this protocol, were performed
according to the Standard Operating Procedures of MRIGlobal.
All study records are stored at MRIGlobal.
Sincerely,
MRIGLOBAL
Rick Tuttle
Principal Scientist
Life Sciences Division
Approved:
Claire R. Croutch, Ph.D.
Portfolio Director
Medical Research
September 17, 2021
Section 1.
Objective:
The objective of this project was to measure the efficacy of the Client’s Airocide HD Air
Purification System (“Test Device”) in elimination and neutralization of aerosolized SARS-CoV-
2 in controlled tests conducted at MRIGlobal. The Client provided a set of two (2) Airocide HD
Air Purifiers. One Test Device was provided with a filter unit and Photocatalytic Oxidation
System (PCO) unit for testing the complete air purification system in viral reduction/elimination.
The other Test Device was delivered with the filter removed for evaluation of the Photocatalytic
Oxidation System (PCO) only for testing the PCO deactivation efficacy of viable virus. Each
Test Device was tested independently for efficacy in aerosol removal/deactivation of SARSCoV-2
aerosols. Aerosol Test Device challenges were conducted in a primary aerosol
containment system within a Class III biological safety cabinet. MRIGlobal characterized the
Test Devices to evaluate the log reduction effectiveness against an enveloped virus (SARSCoV-2
Washington State Isolate Strain or USA-WA1/2020).